RAMP1 and migraine disorder: This partial reduction of chronic migraine symptoms correlates with our observations of approximately 50% attenuation of migraine symptoms in mice with impaired lymphatic response to CGRP compared with the total prevention, as observed in Ramp1–/– mice.